Local Institution - 403

Innsbruck 6020

0 studies enrolling now · 1 studies all time

What they study most

Lymphoma, Non-Hodgkin

Studies at this site

• A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Completed